Found: 2
Select item for more details and to access through your institution.
Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 1995, doi. 10.1111/dom.14116
- By:
- Publication type:
- Article
1087-P: A Randomized Pragmatic Real-World Clinical Trial Comparing Insulin Glargine 300 U/mL (Gla-300) with Standard of Care First-Generation Basal Insulins (SoC-BIs) in Insulin-Naïve Patients with Type 2 Diabetes: Twelve-Month Analysis of the ACHIEVE Control Study
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1087-P
- By:
- Publication type:
- Article